📰 Lab Diagnostics News
Page 2 - Lab Diagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lab Diagnostics. Real-time updates on events, politics, business and more.
March 15, 2023
Despite recent advancements, many highly sensitive diagnostic tests for viral diseases still require complicated techniques to prepare a sample or interpret a result, making them impractical for point-of-care settings or areas with few resources.
March 14, 2023
Yersinia bacteria cause a variety of human and animal diseases, the most notorious being the plague, caused by Yersinia pestis.
March 13, 2023
As conventional antibiotics continue to lose effectiveness against evolving pathogens, scientists are keen to employ the bacteria-killing techniques perfected by bacteriophages, the viruses that infect bacteria.
March 5, 2023
Pain afflicts at least 1.5 billion people worldwide, and despite the availability of various painkilling drugs, not all forms of pain are treatable.
March 5, 2023
The animal brain consists of tens of billions of neurons or nerve cells that perform complex tasks like processing emotions, learning, and making judgments by communicating with each other via neurotransmitters.
February 24, 2023
EPFL researchers have published a method for 3D-printing an ink that contains calcium carbonate-producing bacteria.
February 24, 2023
Researchers assessed the association between deoxyribonucleic acid methylation (DNAm)-based clocks or aging measures and demographic and serological parameters in estimating health-associated outcomes, including deaths.
February 22, 2023
The human body can predict the timing of regular meals, according to a new study from the University of Surrey.
February 21, 2023
Once thought incapable of encoding proteins due to their simple monotonous repetitions of DNA, tiny telomeres at the tips of our chromosomes seem to hold a potent biological function that's potentially relevant to our understanding of cancer and aging.
February 17, 2023
People afflicted with autoimmune diseases may someday receive help through treatments now under development by a Lawrence Livermore National Laboratory licensee and its' collaborations with two major pharmaceutical companies.